PAF
Member
- Joined
- Feb 26, 2012
- Messages
- 13,582
Moderna, Bill Gates, U.S. Federal Funding, Trump's "Warp Speed" Appointee Dr. Moncef Slaoui
____
Moderna Soars After Getting $483 Million in Federal Funding for Coronavirus Vaccine Development
https://www.cnbc.com/2020/04/17/moderna-soars-on-483-million-in-funding-for-coronavirus-vaccine.html
____
In 2016, Moderna Wins Initial $20M Grant from Gates Foundation.
The grant is intended for use in the antibody combination's preclinical study and a Phase I clinical trial. Gates Foundation’s $20 million funding could potentially grow into a total $100 million commitment—including the HIV antibody project—toward development of additional mRNA-based treatments for various infectious diseases, Moderna said.
https://www.genengnews.com/topics/omics/moderna-wins-initial-20m-grant-from-gates-foundation/
____
The effort is funded by the Coalition for Epidemic Preparedness Innovations, a group started by Norway and India, the Bill & Melinda Gates Foundation, the Wellcome Trust, and the World Economic Forum.
Moderna said the NIH will soon run early studies to allow for human testing, with plans to start a clinical trial in the US. Moderna did not specify a development timeline.
Moderna, a $7 billion biotech, on Thursday announced a collaborative effort with the National Institutes of Health to use its genetic drug development platform to produce an experimental vaccine. The biotech Inovio is also working on a vaccine, as are researchers at the University of Queensland, according to the Coalition for Epidemic Preparedness Innovations, which is funding the efforts.
CEPI was started by Norway and India, the Bill & Melinda Gates Foundation, the Wellcome Trust, and the World Economic Forum.
https://www.businessinsider.com/vac...-cornonavirus-moderna-inovio-cepi-2020-1?op=1
____
Moderna
Executive
Since 2011, Moderna has been led by CEO Stéphane Bancel, a French businessman who is not a scientist and comes from a pharma sales and operations background. Bancel has been described as having a secretive approach to Moderna, and of being a tough operator. Though never having worked with RNA before, Stat noted that Bancel "is listed as a co-inventor on more than 100 of Moderna's early patent applications, unusual for a CEO who is not a PhD scientist". After Noubar Afeyan and Robert Langer, Bancel is the largest individual shareholder in the company.
Stephen Hodge is President and a former McKinsey & Company management consultant who joined in 2012; he is the fourth-largest individual shareholder in the company.
Lorence Kim is CFO and a former Goldman Sachs biotech investment banking managing director who joined in 2014; he is the fifth-largest individual shareholder in the company.
Board
Since 2011, the Chairman of Moderna has been the CEO of Flagship Pioneering, businessman Noubar Afeyan. Afeyan holds his interest in Moderna through various Flagship Pioneering vehicles, however, at the 2018 IPO, documents filed stated that Afreyan owned 19.5% of the company, while Flagship owned 18%, thus giving Afreyan control over 37.5% of the company.
In May 2020, board member Dr. Moncef Slaoui resigned from the company to become Chief Scientist for the Trump administration's "Operation Warp Speed", a group designed to accelerate the development of a vaccine for the coronavirus.
Slaoui continued to hold more than $10 million in stock options in the company in his new role while the Federal government invested $483 million in the company to assist in coronavirus vaccine trials.
Senator Elizabeth Warren called the holding a conflict of interest and that Slaoui should have divested his options.
https://en.wikipedia.org/wiki/Moderna
____
Moderna Soars After Getting $483 Million in Federal Funding for Coronavirus Vaccine Development
https://www.cnbc.com/2020/04/17/moderna-soars-on-483-million-in-funding-for-coronavirus-vaccine.html
____
In 2016, Moderna Wins Initial $20M Grant from Gates Foundation.
The grant is intended for use in the antibody combination's preclinical study and a Phase I clinical trial. Gates Foundation’s $20 million funding could potentially grow into a total $100 million commitment—including the HIV antibody project—toward development of additional mRNA-based treatments for various infectious diseases, Moderna said.
https://www.genengnews.com/topics/omics/moderna-wins-initial-20m-grant-from-gates-foundation/
____
The effort is funded by the Coalition for Epidemic Preparedness Innovations, a group started by Norway and India, the Bill & Melinda Gates Foundation, the Wellcome Trust, and the World Economic Forum.
Moderna said the NIH will soon run early studies to allow for human testing, with plans to start a clinical trial in the US. Moderna did not specify a development timeline.
Moderna, a $7 billion biotech, on Thursday announced a collaborative effort with the National Institutes of Health to use its genetic drug development platform to produce an experimental vaccine. The biotech Inovio is also working on a vaccine, as are researchers at the University of Queensland, according to the Coalition for Epidemic Preparedness Innovations, which is funding the efforts.
CEPI was started by Norway and India, the Bill & Melinda Gates Foundation, the Wellcome Trust, and the World Economic Forum.
https://www.businessinsider.com/vac...-cornonavirus-moderna-inovio-cepi-2020-1?op=1
____
Moderna
Executive
Since 2011, Moderna has been led by CEO Stéphane Bancel, a French businessman who is not a scientist and comes from a pharma sales and operations background. Bancel has been described as having a secretive approach to Moderna, and of being a tough operator. Though never having worked with RNA before, Stat noted that Bancel "is listed as a co-inventor on more than 100 of Moderna's early patent applications, unusual for a CEO who is not a PhD scientist". After Noubar Afeyan and Robert Langer, Bancel is the largest individual shareholder in the company.
Stephen Hodge is President and a former McKinsey & Company management consultant who joined in 2012; he is the fourth-largest individual shareholder in the company.
Lorence Kim is CFO and a former Goldman Sachs biotech investment banking managing director who joined in 2014; he is the fifth-largest individual shareholder in the company.
Board
Since 2011, the Chairman of Moderna has been the CEO of Flagship Pioneering, businessman Noubar Afeyan. Afeyan holds his interest in Moderna through various Flagship Pioneering vehicles, however, at the 2018 IPO, documents filed stated that Afreyan owned 19.5% of the company, while Flagship owned 18%, thus giving Afreyan control over 37.5% of the company.
In May 2020, board member Dr. Moncef Slaoui resigned from the company to become Chief Scientist for the Trump administration's "Operation Warp Speed", a group designed to accelerate the development of a vaccine for the coronavirus.
Slaoui continued to hold more than $10 million in stock options in the company in his new role while the Federal government invested $483 million in the company to assist in coronavirus vaccine trials.
Senator Elizabeth Warren called the holding a conflict of interest and that Slaoui should have divested his options.
https://en.wikipedia.org/wiki/Moderna
Last edited: